According to a new report published by OG Analysis, the global Internet of Medical Things (IoMT) Market was valued at USD 99.1 billion in 2026 and is projected to reach USD 425.4 billion by 2034, expanding at a CAGR of 19.98% during the forecast period.

Market Overview

The market comprises connected medical devices, sensors, software platforms, networking technologies, cloud infrastructure, analytics, and cybersecurity capabilities that collect, transmit, exchange, and analyze health-related data across clinical and non-clinical environments. Connected healthcare ecosystems span wearable health monitors, implantable devices, remote patient monitoring systems, smart diagnostic equipment, connected imaging systems, infusion pumps, hospital asset-tracking solutions, and medication-management devices. Adoption is accelerating as hospitals and care networks pursue continuous patient visibility, automated data capture, device-to-device communication, predictive analytics, telehealth integration, and hospital-to-home care. The shift toward AI-enabled diagnostics, 5G connectivity, interoperable medical-device platforms, smart hospitals, and subscription-based digital health services is also increasing recurring software and service revenue per connected endpoint.

Key Market Insights

●       The market is valued at USD 99.1 billion in 2026 and is forecast to reach USD 425.4 billion by 2034, reflecting rapid expansion of connected medical devices, cloud platforms, remote monitoring, analytics, and associated digital services.

●       North America leads with 38% market share in 2026, supported by mature healthcare IT infrastructure, strong remote patient monitoring adoption, reimbursement availability, cloud deployment, and high medtech spending; Asia-Pacific is the fastest-growing region.

●       Wearable Devices lead device type with 41% share, reflecting increasing use of continuous glucose monitors, wearable ECG systems, smart health patches, connected biosensors, and other medical-grade monitoring devices.

●       Real-Time Monitoring is the leading application with 35% share, driven by continuous vital-sign monitoring, chronic disease management, early deterioration detection, automated clinical alerts, and hospital-to-home monitoring.

●       Healthcare Providers account for 51% of end-user demand as hospitals, clinics, and care networks expand connected monitoring, smart medical equipment, device-management platforms, and integrated digital-health infrastructure.

Market Dynamics

●       Driver: Rising demand for remote patient monitoring, chronic-disease management, hospital-at-home programs, and telehealth is expanding the installed base of connected medical endpoints across hospitals and home-care environments.

●       Driver: Healthcare providers are investing in smart hospitals, cloud healthcare platforms, AI-enabled diagnostics, 5G connectivity, and automated clinical workflows to improve outcomes, reduce readmissions, and optimize medical-device utilization.

●       Opportunity: Interoperability with electronic health records, clinical communication tools, analytics platforms, and multi-vendor device fleets is becoming a key procurement requirement and creates opportunities for device-neutral integration platforms.

●       Restraint: Cybersecurity, patient-data privacy, vulnerability management, software patching, and compliance requirements increase deployment complexity and lifecycle-management costs across heterogeneous connected medical-device fleets.

●       Restraint: Fragmented data standards, legacy hospital infrastructure, integration burdens, and limited technical resources can slow adoption and make large-scale connected-care implementations difficult to standardize.

●       Opportunity: AI-driven edge analytics, predictive monitoring, personalized alert thresholds, and automated triage can reduce alarm fatigue and convert continuous data streams into more clinically actionable insights.

●       Opportunity: Home-based care, wearable monitoring, connected diagnostics, and digitally enabled chronic-care programs are expanding addressable demand, particularly as healthcare systems seek lower-cost alternatives to facility-based monitoring.

Browse for More Information

https://www.oganalysis.com/industry-reports/internet-of-medical-things-iomt-market

Market Segmentation

The market is segmented by Device Type into Wearable Devices, Stationary Devices, Implantable Devices, and Other Devices. By Application, it includes Data Assortment and Analysis, Real-Time Monitoring, Remote Medical Assistance, Tracking and Alerts, and Other Applications. By End User, the market covers Healthcare Providers, Patients, Government Authorities, and Other End Users. Geographically, the industry is analyzed across North America, Europe, Asia-Pacific, the Middle East and Africa, and South and Central America.

Regional Insights

●       North America: Leads with 38% share in 2026, supported by advanced healthcare IT infrastructure, widespread remote monitoring, reimbursement support, high connected-device penetration, cloud adoption, and strong medtech spending.

●       Asia Pacific: Represents the fastest-growing region, driven by healthcare digitization, expanding 5G infrastructure, smart-hospital investment, large patient populations, telehealth adoption, and growing use of connected healthcare devices across China, India, Japan, South Korea, and Southeast Asia.

●       Europe: Maintains a significant position owing to mature healthcare infrastructure, connected-care adoption, interoperability initiatives, digital-health programs, and demand for secure, compliant device connectivity across hospital networks.

●       South & Central America and Middle East & Africa: Offer developing opportunities as healthcare connectivity, remote-care infrastructure, mobile health platforms, and smart hospital investments expand across major urban healthcare systems.

Competitive Landscape

The competitive landscape spans global medtech manufacturers, connected-monitoring specialists, cloud and software providers, networking companies, and digital-health platform vendors. Competition is increasingly shaped by device connectivity, remote monitoring, interoperability, cybersecurity-by-design, AI-enabled analytics, cloud integration, recurring software services, device lifecycle management, and electronic health record connectivity. Leading suppliers are building broader device-to-cloud ecosystems, expanding wearable and home-monitoring capabilities, strengthening strategic partnerships with health systems, and using AI and data platforms to improve clinical relevance and workflow automation.

Key players include Medtronic, Philips, GE HealthCare, Siemens Healthineers, Abbott Laboratories, Johnson & Johnson, Baxter International, Becton Dickinson, Boston Scientific, Stryker, Zimmer Biomet, Roche, Dexcom, ResMed, Masimo, iRhythm Technologies, BIOTRONIK, Omron Healthcare, Terumo, Edwards Lifesciences, Intuitive Surgical, AliveCor, Cisco Systems, Microsoft, Oracle, IBM, Honeywell, Intel, and Qualcomm Life.

Recent Developments

●       August 2026: Philips expanded its open patient-monitoring ecosystem through collaborations with Blue Spark Technologies, Caretaker Medical, Cuviva, LifeSignals, Respiree, and smartQare, integrating wearable and out-of-hospital monitoring technologies into a connected-care environment spanning hospital and home recovery.

●       July 2026: Dexcom became the first participant selected for the U.S. FDA TEMPO Digital Health Devices Pilot Program and plans to combine G7 and Stelo biosensor data with nutrition, activity, sleep, and stress information to support AI-powered personalized insights.

●       June 2026: Philips and University Health in San Antonio entered a long-term agreement to deploy Enterprise Monitoring as a Service, including centralized monitoring, remote telemetry, alarm management, analytics, and connected patient surveillance across the health system.

●       June 2026: Medtronic expanded its remote patient-monitoring portfolio through an agreement with Corsano Health to exclusively distribute Corsano's FDA-cleared multi-parameter wearable in the United States for hospital and hospital-to-home monitoring.

●       May 2026: Abbott received CE Mark for Libre Duo and Libre Duo 10 Day connected glucose-and-ketone sensing systems, extending continuous monitoring and data sharing within its Libre digital-health ecosystem and supporting compatibility with automated insulin-delivery systems.